aod9604 buy uk AOD 9604 (5mg) Research Peptide - Laboratory Use Only AOD9604 2mg
Description
At 10% concentration, this delivers approximately 0.5%-2% active AHK-Cu peptide in the finished product, which is within the scientifically validated effective range
It was originally developed by Metabolic Pharmaceuticals in Australia during the late 1990s as a potential **anti-obesity peptide** that could stimulate fat loss without the growth-promoting or diabetogenic effects of full-length growth hormone
It is used to treat or prevent vitamin B12 deficiency caused by conditions such as pernicious anemia, low dietary intake, certain gastrointestinal disorders, or surgeries that reduce absorption
A mouse model of diet-induced obesity and insulin resistance
doi: 10.1210/en.2006-0453
A study showed that people with diabetic neuropathy got better symptoms with regular B12 shots
